Skip to main content
CCM logo

Concord Medical Services Holdings Limited (CCM) Stock Price & Analysis

Concord Medical Services Holdings Limited (CCM) — MoonshotScore 26/100 (Weak band), calculated Nov 18, 2026. Price $3.41 (-5.36%), as of the Nov 19, 2026 trading session; market cap $14.8M.

Educational signal · not a buy or sell recommendation · How to read this

$3.41 −$0.2021 (-5.36%) Market Cap $14.8M

Concord Medical Services Holdings Limited · CCM · NYSE

Concord Medical Services Holdings Limited operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company provides a range of services including radiotherapy, diagnostic imaging, and clinical support.

Price as of Nov 19, 2026

Key Statistics

26 of 100

MoonshotScore v2 · Concord Medical Services Holdings (CCM)

Weak
Business Quality Average (46)
Financial Safety Fortress (81)
Valuation Bubble (12)
Growth Durability Growing (76)
Momentum Quiet (50)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

A strong balance sheet and durable growth, but an expensive valuation. The score also carries a risk penalty for a bankruptcy-risk score in the distress zone and losses on top of negative retained earnings. Business Quality: Average; Financial Safety: Fortress; Valuation: Bubble; Growth Durability: Growing; Momentum: Quiet.

Earnings yield is the main valuation drag relative to sector peers.

  • quarterly revenue CN¥255M (Q4 FY2025, quarter ended Dec 31, 2025)
  • Altman Z -1.19 · Piotroski F 6
  • ROE 5.2% · ROA -1.7% · current ratio 0.48

Holding back: a rich price

Helping: balance-sheet strength, durable growth

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for CCM (57 recorded, newest six shown)
RecordedScoreBand
30Weak
26Weak
26Weak
26Weak
26Weak
26Weak

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$3.41
Change on the day-5.36%
52-week range$2.79 – $6.80
Market capitalisation$14.8M—
Shares traded on the day18.3K

Price & events

Other perspectives

Council score for Concord Medical Services Holdings (CCM): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Neutral
Financial Safety Strong
Valuation Negative
Growth Durability Moderate
Momentum Neutral

Legends Council

3 lenses, 3 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Unfavorable read

Read on: Nov 19, 2026

Munger's Mindset

Balance Sheet & Valuation

Financial Health Weak
Margin of Safety Fairly Valued
Profit Margin Weak
Debt/Equity Negative
ROE Neutral
Gross Margin Negative

Read on: Nov 19, 2026

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

The Munger lens reads the current price as fairly valued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Concord Medical Services Holdings (CCM), and what does it report?

Short answer

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Concord Medical Services Holdings Limited (CCM) is listed on NYSE. It employs 610 people and is led by Jianyu Yang. In Q4 FY2025 it reported revenue of CN¥255M and net income of -CN¥64M. The market values it at $14.8M.

2 · Latest results

What do the latest results show for Concord Medical Services Holdings (CCM)?

Short answer · as of

The most recent reported quarter, Q4 FY2025, carried revenue of CN¥255M.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q4 FY2025CN¥255M-CN¥64M-CN¥444.60 (diluted)
Q3 FY2025CN¥130M-CN¥33M-CN¥225.60 (diluted)
Q2 FY2025CN¥100M-CN¥14M-CN¥94.50 (diluted)
Q1 FY2025CN¥100M-CN¥14M-CN¥94.50 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Concord Medical Services Holdings (CCM)?

Short answer

The MoonshotScore pillars rate balance-sheet strength, durable growth as strengths. What is holding it back is a rich price. The distress and quality screens read Altman Z -1.19 · Piotroski F 6. Trailing ratios: ROE 5.2% · ROA -1.7% · current ratio 0.48.

4 · What to check next?

What should you watch next at Concord Medical Services Holdings (CCM)?

Short answer · as of

Analyst estimates on file carry FY2026 revenue $440.38M · EPS -18.25 · 1 analysts.

What the records here don't tell us

  • The next earnings date is not yet scheduled in the calendar we read.
  • No insider Form 4 transaction falls inside the window this page reads.
  • The newest quarter held here (Q4 FY2025) was filed Apr 29, 2026 — 6 months ago.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does Concord Medical Services Holdings compare with its peers?

Short answer

Concord Medical Services Holdings's score ranks 12th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
AMN Healthcare Services, Inc. (AMN) Same industry, near in market value$34.35 Nov 19, 2026$1.32B93 5-pillar Nov 18, 2026
InnovAge Holding Corp. (INNV) Same industry, near in market value$8.91 Nov 19, 2026$1.22B92 5-pillar Nov 18, 2026
The Joint Corp. (JYNT) Same industry, near in market value$6.43 Nov 19, 2026$88.0M73 5-pillar Nov 18, 2026
The Pennant Group, Inc. (PNTG) Same industry, near in market value$34.09 Nov 19, 2026$1.20B68 5-pillar Nov 18, 2026
Auna S.A. (AUNA) Same industry, near in market value$3.90 Nov 19, 2026$289M59 5-pillar Nov 18, 2026
Community Health Systems, Inc. (CYH) Same industry, near in market value$1.61 Nov 19, 2026$227M52 5-pillar Nov 18, 2026
American Shared Hospital Services (AMS) Same industry, near in market value$1.05 Nov 19, 2026$7.01M43 5-pillar Nov 18, 2026
biote Corp. (BTMD) Same industry, near in market value$0.84 Nov 19, 2026$27.3M39 5-pillar Nov 18, 2026
Cryo-Cell International, Inc. (CCEL) Same industry, near in market value$4.15 Nov 19, 2026$33.5M33 5-pillar Nov 18, 2026
AirSculpt Technologies, Inc. (AIRS) Same industry, near in market value$0.65 Nov 19, 2026$48.4M33 5-pillar Nov 18, 2026
P3 Health Partners Inc. (PIII) Same industry, near in market value$1.86 Nov 19, 2026$385M31 5-pillar Nov 18, 2026
Concord Medical Services Holdings (CCM) — this page$3.41$14.8M26
COMPASS Pathways plc (CMPS) Same industry, near in market value$8.65 Nov 19, 2026$1.23B23 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Analyst targets & estimates

What analysts have on file

Revenue estimate
$440.38M
EPS estimate
$-18.25

Measured against a quoted price of $3.41 (as of Nov 19, 2026).

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held CCM in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported CCM in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What Investors Ask About Concord Medical Services Holdings (CCM)

These answers are editorial: 1 of these 9 answers is drawn from the CCM research dossier (written Mar 15, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for CCM?

CCM carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Is CCM a good stock to buy?

Stock Expert AI does not rate CCM buy, sell or hold. Concord Medical Services Holdings Limited carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the CCM stock price today?

The last price recorded for Concord Medical Services Holdings Limited (CCM), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What do analysts say about CCM stock?

There is no analyst consensus available in the provided data. Investors should conduct their own due diligence and consult with a financial advisor before making any investment decisions.

What are the key factors to evaluate for CCM?

Concord Medical Services Holdings Limited (CCM) holds a MoonshotScore in the low range. These techniques offer more precise and effective cancer treatment, attracting patients seeking advanced care. Not financial advice.

How frequently does CCM data refresh on this page?

CCM's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven CCM's recent stock price performance?

Concord Medical Services Holdings Limited (CCM) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established network of radiotherapy and diagnostic imaging centers in China. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider CCM overvalued or undervalued right now?

Concord Medical Services Holdings Limited (CCM) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of CCM?

Fractional-share availability for Concord Medical Services Holdings Limited (CCM) depends on your brokerage, account and supported securities. Check the broker's current eligibility, minimums and fees before placing an order.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 18 figures on this page — 7 from Financial Modeling Prep (FMP), 9 with no recorded source and 2 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.